Cart
This product is not clubbable with other items in cart. Please remove this or other items to proceed further.
Deleting

No Items In Cart
We apologize your item could not be found. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
As China has become the fastest-growing market in generic drugs, China Food and Drug Administration (CFDA) is paying more attention to drug quality and setting a higher standard for pharmaceutical packaging. Compatibility of the drug with the packaging materials is one critical focus area.
Now China is experiencing a change from Registration System to Bundling Review, and there is greater emphasis on the drug manufacturers to provide a more comprehensive evaluation regarding the suitability of the packaging materials with the drug products. CFDA has published Compatibility of Chemicals and Elastomer Closures in the China Draft Technical Guideline (CTG), which details the requirements for extractables and leachables (E&L) studies.
As E&L is a critical subject for domestic drug manufacturers, many of them would have the following questions on how to proceed:
West proposes the above roadmap and can provide further support as needed, both in the design of experiments, and the performance of experiments by West Analytical Laboratory Services. Contact your Account Manager or Technical Customer Support (TCS) representative for more.